Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 How academically productive are endocrine surgeons in the United States?Journal of Surgical Research.  229:122-126. 2018
2018 Reducing cost and improving operating room efficiency: examination of surgical instrument processingJournal of Surgical Research.  229:15-19. 2018
2016 Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.American Surgeon.  82:1133-1139. 2016
2016 Improved postoperative survival for intraductal- growth subtype of intrahepatic cholangiocarcinomaAmerican Surgeon.  82:1133-1139. 2016
2016 Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma 2016
2016 Timed Stair Climbing is the Single Strongest Predictor of Perioperative Complications in Patients Undergoing Abdominal SurgeryJournal of The American College of Surgeons.  222:559-566. 2016
2016 Compromised Outcome of Papillary Thyroid Cancer at Low-Volume Treatment Centers: Practice Makes Perfect?Annals of Surgical Oncology.  23:355-357. 2016
2015 Anaplastic thyroid carcinoma, version 2.2015 2015
2014 Thyroid carcinoma, version 2.2014. 2014
2014 Thyroid carcinoma, version 2.2014: Featured updates to the NCCN guidelines 2014
2010 Thyroid carcinoma 2010
2010 Medullary carcinoma. 2010
2010 Medullary carcinoma: Clinical practice guidelines in oncology™ 2010
2009 The role of angiocidin in sarcomasCancer.  115:5251-5262. 2009
2009 Fibroblast-conditioned media promote human sarcoma cell invasionSurgery.  145:42-47. 2009
2005 Macrophage inflammatory protein-3α promotes pancreatic cancer cell invasionJournal of Surgical Research.  123:96-101. 2005
2004 Co-localization of macrophage inflammatory protein-3α (Mip-3α) and its receptor, CCR6, promotes pancreatic cancer cell invasion 2004
2004 Antiangiogenic therapyCurrent Pharmaceutical Design.  10:27-37. 2004
2002 Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 productionSurgery.  132:220-225. 2002
2001 Neoadjuvant therapy for gastric cancerAsian Journal of Surgery.  24:235-241. 2001
1997 Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cellsExperimental Cell Research.  235:403-412. 1997
1997 Adhesive proteins and the hematogenous spread of cancerActa Haematologica.  97:29-39. 1997
1997 Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin systemSurgery.  122:493-500. 1997
1996 Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptorSurgery.  120:449-454. 1996
1996 Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancerJournal of Surgical Research.  63:39-43. 1996
1995 The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen 1995

Education And Training

  • Doctor of Philosophy, Drexel University 1999
  • Doctor of Medicine, Temple University 1991
  • Hahnemann University Hospital, Internship 1992
  • Hahnemann University Hospital, Residency 1999
  • MD Anderson Cancer Center, Postdoctoral Fellowship 2001
  • Full Name

  • Thomas Wang